Virtual reality ‘gaming’ used to plan delicate cancer surgeries

Ontario teenager Emeric Leblanc has become one of the first patients in Canada to undergo surgery for a rare bone cancer using a newly developed virtual reality (VR) system. The tech—modeled after video games—is designed by Ottawa-based startup Realize Medical, and it allows surgeons to navigate a simulation of a patient's body in a virtual space, in an effort to plan complex surgeries.

According to coverage from CTV News, Leblanc was diagnosed with Ewing sarcoma, and previously underwent chemotherapy and radiation. It was then that the surgical team at the Ottawa Hospital Cancer Program used the VR system to visualize and plan the removal of a 12-centimeter tumor engulfing much of his left hip bone.

Led by Dr. Joel Werier, the surgical team faced the challenge of removing the tumor while preserving enough pelvic bone to support Leblanc's hip joint. The VR system provided a three-dimensional view of the affected area, helping the surgeons make critical decisions. Medical teams are able to create 3D images from CT and MRI scans, providing a more immersive and detailed perspective for planning surgeries.

Realize Medical received clearance from the U.S. Food and Drug Administration in January 2023 for deployment in the U.S. and their VR is now being used in 18 hospitals stateside for planning cancer surgeries and other delicate medical procedures.

Ongoing studies in Canada are exploring the broader applications of VR in planning surgeries for various medical conditions, including heart, lung, and transplant operations.

For more, read the full CTV News story at the link below.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup